BRUSCHETTA, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 862
NA - Nord America 774
AS - Asia 218
Totale 1.854
Nazione #
US - Stati Uniti d'America 774
IE - Irlanda 245
PL - Polonia 230
CN - Cina 201
SE - Svezia 182
IT - Italia 132
FI - Finlandia 23
GB - Regno Unito 23
BE - Belgio 17
VN - Vietnam 14
FR - Francia 2
IN - India 2
RU - Federazione Russa 2
UA - Ucraina 2
AT - Austria 1
CH - Svizzera 1
DE - Germania 1
KR - Corea 1
NL - Olanda 1
Totale 1.854
Città #
Dublin 245
Warsaw 230
Chandler 179
Nyköping 144
Ann Arbor 69
Beijing 67
Messina 50
Princeton 46
Dearborn 35
Houston 33
Jacksonville 32
Des Moines 29
Medford 27
Ashburn 26
Cambridge 22
Boardman 19
Jinan 18
Brussels 17
Lancaster 17
Shenyang 15
Dong Ket 14
San Mateo 13
Hebei 11
Tianjin 11
Haikou 10
Milan 9
Nanjing 9
Taizhou 9
Fairfield 6
Guangzhou 6
Rome 6
Falls Church 5
Ningbo 5
Wilmington 5
Zhengzhou 5
Cagliari 4
Francofonte 4
Fuzhou 4
Lanzhou 4
Nanchang 4
New York 4
Noto 4
Acireale 3
Catania 3
Hefei 3
Norwalk 3
Taiyuan 3
Woodbridge 3
Carpi 2
Hangzhou 2
Jiaxing 2
Pune 2
Sannicandro Di Bari 2
Tappahannock 2
Turin 2
Aci Sant'antonio 1
Augusta 1
Bologna 1
Bordeaux 1
Brooklyn 1
Caltanissetta 1
Caserta 1
Catanzaro 1
Changsha 1
Chicago 1
Chieti 1
Ferrara di Monte Baldo 1
Florence 1
Jinju 1
Klyuchik 1
Lappeenranta 1
London 1
Los Angeles 1
Meppel 1
Montechiarugolo 1
Parma 1
Pavia 1
Piazza Armerina 1
Reggio Emilia 1
Riva 1
Scafati 1
Seattle 1
Strasbourg 1
Vienna 1
Totale 1.533
Nome #
The role of central PRCP in the metabolism regulation 249
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 89
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 84
The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats 83
Dimethyl fumarate reduces inflammatory responses in experimental colitis 81
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 78
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 69
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 65
N-palmitoylethanolamine administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents 64
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution 64
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 61
The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. 59
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 57
2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation 52
Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-UM®) in Myocardial Ischaemia and Reperfusion Injury in Vivo 51
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 51
Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice 51
B Cell-Targeted Therapy with Anti-CD20 Monoclonal Antibody Reduced Secondary Tissue Damage and Enhanced Behavioural Recovery Following Experimental Spinal Cord Injury in Mice 50
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 47
Ultramicronized palmitoylethanolamide reduces inflammation an a Th1-mediated model of colitis 46
Traumatic Brain Injury Leads to Development of Parkinson's Disease in Mice 42
Emerging drugs for acute lung injury. 41
FeTTPs treatment reduces secondary injury associated in a mouse model of traumatic brain injury 41
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man 38
Effect of co-ultramicronized palmitoylethanolamide and luteolin association on neurogenesis in a mouse model of spinal cord injury 37
null 36
Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats 35
PEA-OXA as new therapeutic strategy to control neuroinflammation in experimental model of spinal cord and brain injury 34
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy 33
PEAOxazoline (PEA-OXA) as a new therapeutic strategy to control neuroinflammation in experimental models of spinal cord and brain injury 30
Temsirolimus promotes autophagic clearance of α-synuclein and provides protective effects in animal models of Parkinson's disease. 26
null 25
null 24
Beneficial effects of co-ultramicronized palmitoylethanolamide/luteolin in a mouse model of autism in a case report of autism 24
Pelagia noctiluca (Scyphozoa) Crude Venom Injection Elicits Oxidative Stress and Inflammatory Response in Rats 21
Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in Mice 10
Totale 1.948
Categoria #
all - tutte 6.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 6 8 2
2019/2020254 1 8 5 16 9 50 21 30 23 57 24 10
2020/2021345 16 12 88 16 44 5 11 43 55 29 8 18
2021/2022256 2 30 2 15 8 3 33 8 5 7 54 89
2022/2023714 62 71 34 66 38 70 3 37 306 5 15 7
2023/2024102 14 30 5 15 9 12 1 12 4 0 0 0
Totale 1.948